New addition to LISA TRACKER, the market’s most complete range of biotherapy monitoring kitsNew test in the field of auto-immune and inflammatory diseasesCroissy-Beaubourg and Montpellier, March 25, 2015 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company…
Four presentations sustaining the relevance of biotherapy monitoring using LISA TRACKER testsOral Presentation by Prof. X. Roblin on the predictive potential of pharmacological level testing associated with other biomarkersStrong interest and increasing use of biotherapy…
Previous Next Croissy-Beaubourg and Montpellier, March 18, 2015 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announced today it has moved into its new Marne-La-Vallée facility, in the Paris…